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INTRODUCTION
Diabetes mellitus is one of the leading chronic 
diseases affecting Australians and its prevalence 
continues to rise. The total number of diabe-
tes patients worldwide is estimated to rise to 
380 million in 2025 from 246 million in 2007 
(Wild et al., 2004). With increasingly growing 
prevalence which includes an estimated 275 
Australians developing diabetes daily (Diabe-
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ABSTRACT
Diabetes	is	one	of	the	leading	chronic	diseases	affecting	Australians	and	its	prevalence	continues	to	rise.	It	is	
becoming	a	serious	challenge	for	both	the	quality	of	healthcare	and	expenditure	in	the	Australian	healthcare	
system.	The	goal	of	this	study	is	to	investigate	the	development	and	application	of	a	pervasive	wireless	tech-
nology	solution	to	facilitate	the	effective	management	of	diabetes	in	the	context	of	women	with	gestational	
diabetes.	Gestational	diabetes	is	a	form	of	diabetes	that	affects	up	to	8%	of	pregnant	women.	A	transactions	
cost	assessment	of	this	solution	is	also	provided.	Integral	to	the	success	of	this	solution	is	the	pervasive	tech-
nology	solution	which	serves	to	support	and	facilitate	superior	diabetes	self-management.
tesAustralia, 2008), Australia is expected to be 
a significant contributor to this projected trend. 
An estimated 700,000 Australians, representing 
approximately 3.6% of the population, were 
diagnosed with diabetes in 2004-05. Between 
1989-90 and 2004-05 the proportion of Aus-
tralians diagnosed with this disease more than 
doubled from 1.3% to 3.3%. Additionally, be-
tween 2000-01 and 2004-05, Australian diabetes 
hospitalizations increased by 35% from 1,932 
to 2,608 hospitalizations per 100,000 people 
(AIHW, 2007, 2008). For every person diag-DOI: 10.4018/jhisi.2011100104
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nosed with diabetes, it is estimated that there 
is another who has yet to be diagnosed, which 
doubles the number of diabetes sufferers (Dia-
betesAustralia, 2008). Diabetes is, thus, one of 
the fastest growing chronic diseases in Australia 
(AIHW, 2008; Catanzariti, Faulks, & Waters, 
2007; Chittleborough et al., 2007). Diabetes 
and its complications incur significant costs for 
the health system in Australia, including costs 
incurred by care providers, government, and 
the entire health system (DiabCostAustralia, 
2002). In 2004-05 direct healthcare expendi-
ture on diabetes was A$907 million, which 
constituted approximately 2% of the recurrent 
health expenditure that is to be allocated in 
that year (AIHW, 2007, 2008). Further costs 
include societal costs that represent productivity 
losses for both patients and their care providers 
(DiabCostAustralia, 2002).
Gestational diabetes mellitus (GDM) is a 
common form of diabetes that presents in preg-
nancy, sometimes with symptoms but often di-
agnosed in otherwise normal women on routine 
screening tests. Some women, particularly those 
in whom the diagnosis of GDM is made early in 
pregnancy, may have pre-existing undiagnosed 
diabetes. In Australia and New Zealand, uni-
versal screening for GDM is recommended by 
the Australasian Diabetes in Pregnancy Society 
(ADIPS) (Hoffman et al., 1998), although the 
uptake of this recommendation is rather variable 
(Rumbold & Crowther, 2001). It is estimated 
that in Australia, 3-6% of pregnant women will 
develop GDM at around 24-28 weeks gesta-
tion, with a smaller number earlier and later in 
pregnancy. An Australian study of 210 pregnant 
women found that screening for GDM had an 
adverse impact on women’s perceptions of their 
own health (Rumbold & Crowther, 2001, 2002). 
GDM is more common in older women, in those 
with a family history of diabetes, in those who 
are overweight, and in those of non-Caucasian 
heritage (Carolan, Steele, & Margetts, 2010). 
Maternal complications of GDM can be serious 
and include polyhydramnios and premature 
labor, maternal hypertension, low birth weights 
and stillbirth (Fan et al., 2006; Hoffman et al., 
1998). It recurs in subsequent pregnancy in 
30-80% of women, the incidence varying with 
ethnicity, being lower in Caucasian women 
(Kim, Berger, & Chamany, 2007).
Treatment of women with GDM aims 
to control maternal, and therefore fetal, hy-
perglycaemia and the associated tendency of 
fetal hyperinsulinaemia which is at the root of 
the fetal complications (Metzger et al., 2008). 
After many years of uncertainty as to the value 
of such treatment in GDM, two trials have now 
shown benefit for both mother and offspring 
for antenatal initiation of lifestyle modification 
and glucose monitoring, coupled with insulin 
therapy as necessary (Crowther et al., 2005; 
Landon et al., 2009). Antenatal treatment of 
detected mild GDM was also associated with 
improved health status for women during the 
antenatal period and at 3 months after birth, 
with less postnatal depression (Crowther et 
al., 2005). Specifically, there is agreement in 
the literature that specific self-management 
activities including glucose monitoring, dietary 
restrictions, and exercise regimes can result in 
good outcomes for mothers and babies sug-
gesting that self-management behaviors can be 
critical (Crowther et al., 2005; Fan et al., 2006).
Recognizing the need to have a solution 
that can enable the ubiquitous monitoring 
of GDM patients while also facilitating self-
management and continuously educating 
them, the goal of this paper is to investigate 
the development and application of DiaMonD 
– a diabetes monitoring device. To the best of 
our knowledge, there exists no other software 
solution that focuses on individuals suffering 
from gestational diabetes; hence the DiaMonD 
solution serves as an exemplar case study in this 
discussion. Specifically, we set out to answer the 
research question “how can DiaMonD benefit 
and facilitate superior care for GDM patients?” 
Powered by pervasive technology software 
developed by INET, DiaMonD is a wireless-
enabled mobile phone that can facilitate superior 
diabetes self-management for GDM patients. 
The realization of this goal can contribute by 
establishing a benchmark for theoretical and 
empirical testing. We examine DiaMonD in the 
context of GDM. Critical to the GDM and to 
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successful pregnancy outcomes is careful and 
systematic monitoring of maternal glycaemia 
and appropriate adjustment of lifestyle, dietary 
and pharmacological therapy in the light of the 
results. The end results of GDM are similar to 
other types of diabetes (e.g., Types 1 and 2). 
However, unlike other types of diabetes, GDM is 
generally transient which can have implications 
on awareness of impacts and self-management 
attitudes (Carolan, Steele, & Margetts, 2010; 
Crowther et al., 2005; Fan et al., 2006).
To achieve our goal, first we provide a 
general background on the Australian health 
scene and critically review existing research 
and then, we elaborate the proposed pervasive 
mobile technology solution and assess it using a 
preliminary transaction cost economics frame-
work. We believe that this paper is, therefore, 
relevant, timely, and important to all players in 
the complex web of healthcare including care 
providers, healthcare organizations, insurers/
payers, regulatory government agencies, pa-
tients, their families, and the community at large.
CURRENT AUSTRALIAN 
HEALTH SCENE
Both healthcare professionals and diabetic pa-
tients require quality information if disease con-
ditions are to be effectively managed. There are 
several deficiencies in the information provided 
by the existing system for monitoring diabetes 
in Australia (Dixon & Webbie, 2006; Sprivulis 
et al., 2007; Swerissen & Taylor, 2008). First, 
data collected in hospitals are episode-based 
rather than patient-based, making it difficult 
to determine statistics concerning individual 
admissions, re-admissions, and treatment pat-
terns. Second, there is a lack of data on incidence 
and prevalence by diabetes type, so as to assess 
reliably the magnitude of the problem. Third, 
the accuracy of recording data in administrative 
data sets, such as hospital morbidity, mortality 
and general practice data, is difficult to ascer-
tain. Finally, clinical management information 
is derived from uncoordinated and fragmented 
data collections that are not representative of the 
entire population of diabetic patients, making 
comparisons, analysis and trend identification 
challenging.
These deficiencies are the result of the 
current health system setup. Based on fee-for-
service episodic doctor-patient consultation, 
the current Australian healthcare system is well 
placed to handle short-term illnesses involv-
ing a limited range of interventions including 
their diagnosis and treatment (Hunt, 2007). 
However, this system is comprised of a mixture 
of fragmented private and public healthcare 
subsystems that provide both healthcare fund-
ing and delivery. Largely uncoordinated, these 
subsystems are deemed to be unsuitable for 
the treatment of long-term chronic diseases, 
including diabetes more generally and GDM in 
particular (Dixon & Webbie, 2006; Sprivulis et 
al., 2007). In fact, the chronic and multisystem 
nature of diabetes and its complications require 
teams of various health professionals and long-
term support to help sufferers make effective 
healthy lifestyle changes and constantly main-
tain them (Hunt, 2007).
CURRENT DIABETES  
SELF-MANAGEMENT 
RESEARCH
As there is no cure for diabetes, non-medical 
approaches are used jointly with medical ap-
proaches, so that patients with the disease can 
have a life which is as normal as possible. 
Non-medical approaches require effective and 
ongoing lifestyle management, together with 
meticulous attention and monitoring by both 
patients and healthcare professionals (Britt 
et al., 2007). Particularly, to be successful, 
patients need to be both informed and active in 
their treatment regimen (AIHW, 2007, 2008). 
These aims can be achieved by effective self-
management, which is a non-medical approach 
and which constitutes the focus of this paper.
Self-management is important as it empow-
ers diabetic patients while acknowledging their 
central role and responsibility for managing 
their healthcare (ICIC, 2008). Active participa-
tion of diabetic patients in self-management 
is a key strategy for managing their condition 
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and reaching improved treatment outcomes 
(Colagiuri, Colagiuri, & Ward, 1998; Poulton, 
1999; Rasmussen, Wellard, & Nankervis, 2001; 
Wellard, Rennie, & King, 2008). However, 
self-management is constantly time-consum-
ing and requires significant self-discipline 
(Russell, Churl Suh, & Safford, 2005) and 
support strategies including assessment, goal-
setting, action-planning, problem-solving and 
follow-up (ICIC, 2008). Moreover, because 
effective self-management may require patient 
interaction with various healthcare profession-
als, including diabetes physicians, general 
practitioners, diabetes educators, dieticians, 
and community nurses (Knuiman, Welborn, 
& Bartholomew, 1996), difficulties can arise 
when diabetic patients encounter problems 
ranging from making appointments to needing 
to travel to many locations (Van Eyk & Baum, 
2002; Wellard, Rennie, & King, 2008; Zigbor 
& Songer, 2001). Given both the importance 
and complexity of applying self-management 
effectively for both prevention and early detec-
tion of diabetes, there are increasing calls for 
further research to facilitate self-management 
(Wellard, Rennie, & King, 2008).
Although current research has provided 
solutions for supporting self-management 
(Chau & Turner, 2006; Rudi & Celler, 2006) 
these have not always been effective due to 
the reality that “patients did not learn how 
to do it [apply the solutions] or they did not 
understand the rules which were explained 
to them, or they are not sure enough of their 
knowledge, uncertainty entailing indecision” 
(Reach et al., 2005). Additionally, a number 
of recent attempts at implementing diabetes 
self-management monitoring systems found 
these systems to be either impractical or costly. 
For example, a system implemented in France 
uses a combination of personal digital assistants 
(PDAs) and mobile phones, but downloads 
glucose readings data weekly or bi-weekly, 
potentially resulting in feedback delays for 
patients and, thus, questionable effectiveness 
and service quality (Farmer et al., 2005). A 
telephone support system was trialed in the 
UK with nurse facilitators. While this system 
was shown to improve glucose readings over-
time, it did not use systematic transmission of 
glucose results, again, potentially impacting 
adversely on effectiveness while also being 
costly to run and maintain (Young et al., 2005). 
Nevertheless, research shows that computer-
assisted telemedicine generally can help people 
with diabetes improve both self-management 
(Balas et al., 2004) and their relationship with 
healthcare professionals (Bodenheimer et al., 
2002; Downer et al., 2006). Here, therefore, 
we investigate the application of a pervasive 
mobile technology solution to facilitate superior 
self-management of GDM.
A TRANSACTION COST 
ECONOMICS ASSESSMENT 
FRAMEWORK
Transaction cost economics (TCE) theory rep-
resents a natural and logical theoretical setting 
for guiding the evaluation of actor interactions 
in a diabetes monitoring healthcare setting (Hes-
terly, Liebeskind, & Zenger, 1990; Hesterly & 
Zenger, 1993; Jones, Hesterly, & Borgatti, 1997; 
Troshani & Rao, 2007a; Williamson, 1991). 
That is, TCE focuses on economic exchange 
relations amongst organizational actors, includ-
ing diabetic patients and healthcare providers 
that are typically involved in interactions. Using 
the TCE extensions proposed by Jones, Hesterly, 
and Borgatti (1997) as a basis, the interactions 
of these actors comprised economic exchanges, 
the efficiency of which is jointly determined by 
four conditions, namely, (1) demand uncertainty, 
(2) task complexity, (3) asset specificity, and (4) 
frequency. We explain these conditions in turn.
Demand uncertainty is defined as the 
inability of an actor to predict future events 
concerning the success or failure of new product 
offerings, such as a diabetes monitoring solu-
tion (Milliken, 1987; Troshani & Rao, 2007a). 
It can be caused by many sources including 
rapid changes in knowledge and technology 
or even by the actors themselves. Understand-
ing potential sources of demand uncertainty is 
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important because it helps control it and reduces 
the impact of associated risks.
Task complexity refers to the number of 
different specialized behavioral inputs that 
are required to fully develop and distribute a 
product or service (Jones, Hesterly, & Borgatti, 
1997; Troshani & Rao, 2007a). Task complex-
ity creates behavioral interdependencies while 
increasing the need for coordinating actors in-
volved in related processes (Pfeffer & Salancik, 
1978; Troshani & Rao, 2007a).
Asset-specific exchanges can be based on 
both unique human (e.g., unique processes and 
knowledge developed by various actors) and 
non-human assets (e.g., unique equipment) 
which actors can use to enable economic ex-
changes. Asset-specific exchanges can therefore 
create dependencies, which, in turn, would 
require enhanced cooperation, coordination, 
and proximity for the effective transfer of as-
sets or their deliverables amongst actors (Jones, 
Hesterly, & Borgatti, 1997; Troshani & Rao, 
2007a; Williamson, 1991).
Frequency concerns how often actors are 
involved in exchanges with each another (Jones, 
Hesterly, & Borgatti, 1997; Williamson, 1985). 
Jones, Hesterly, and Borgatti (1997) argue 
that “frequency allows human asset specific-
ity to develop from learning-by-doing and to 
“deepen” through continued interaction; this 
creates exchanges where the “identity” of the 
other [actors] matters and enhances the trans-
fer of tacit knowledge…” (p. 922) while also 
maximizing the cost efficiencies of existing 
interaction structures (Troshani & Rao, 2007a; 
Williamson, 1985).
DEVELOPMENT OF A 
PERVASIVE MOBILE 
TECHNOLOGY SOLUTION
In our case exemplar, we examine DiaMonD, 
a diabetes monitoring device, as a solution 
which incorporates software that facilitate 
the ubiquitous monitoring of an individual’s 
GSM, thereby, contributing to diabetes self-
management. The solution is grounded in trying 
to support key components of a chronic disease 
care model (Table 1).
INET International Inc.’s research (Gold-
berg, 2002a, 2002b, 2002c, 2002d, 2002e, 2009; 
Wickramasinghe & Goldberg, 2003, 2004) starts 
with a 30-day e-business acceleration project 
in collaboration with many key players in 
hospitals, such as clinicians, medical units, 
administration, and IT departments. Together, 
they follow a rigorous procedure that refo-
cuses the traditional 1-5-year system develop-
ment lifecycle (SDLC) into concurrent 30-day 
projects to accelerate healthcare delivery im-
provements. At completion, an e-business ac-
celeration project delivers a scope document 
to develop a handheld technology application 
(HTA) proof-of-concept specific to the unique 
needs of a particular environment. The proof-
of-concept is a virtual lab case scenario which 
operates within a mobile Internet (wireless) 
environment by working with hospitals and 
technology vendors. The final step is the col-
lection of additional data with clinical HTA 
trials consisting of two-week hospital evalua-
tions.
The INET web-based model (Figure 1) 
provides the necessary components to enable 
the delivery framework to be positioned in the 
best possible manner so it can indeed facilitate 
enacting the key components of the chronic dis-
ease model successfully (Table 1). The model is 
positioned to suit the complex nature of health-
care environments by iteratively, systematically, 
and rigorously incorporating lessons learnt data 
to healthcare processes for ensuring superior 
healthcare delivery. This not only maximizes 
the value of past data and organizational learn-
ing, but it also makes processes amendable as 
complex needs and requirements evolve.
It is important to note that in the INET 
web-based model the three key areas of risk, 
namely, people, processes and technology, are 
minimized through the use of pervasive technol-
ogy, which we believe is a unique benefit of 
the INET solution. Specifically, since the pro-
posed solution is an application that is compat-
ible with any mobile phone or wireless device 
(e.g., a PDA), data transfers occur between 
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patients and providers on a well-vetted model. 
Therefore, the learning curve for patients may 
be minimal as they are likely to be in possession 
of mobile devices. We note that while the INET 
model was developed to provide self-manage-
ment support for any/all diabetes sufferers, the 
focus of this paper is primarily on patients suf-
fering from GDM, i.e., a specific subset of all 
diabetes sufferers.
What makes this model unique and most 
beneficial is its focus on enabling and supporting 
all areas necessary for the actualization of ICT 
initiatives in healthcare. By design, the model 
identifies the inputs necessary to bring an in-
novative chronic disease management solution 
to market. These solutions are developed and 
implemented through a physician-led mobile 
e-health project. This project is the heart of the 
model that bridges the needs and requirements 
of many different players into a final (output) 
deliverable, a “Wireless Healthcare Program”.
To accomplish this, the model is continu-
ally updated to identify, select and prioritize 
the ICT project inputs that will:
• Accelerate healthcare system enhance-
ments and achieve rapid healthcare ben-
efits. The model identifies key healthcare 
system inputs with the four Ps, namely:
1)  People that deliver healthcare,
2)  Process to define the current healthcare 
delivery tasks,
3)  Platform used in the healthcare tech-
nology infrastructure,
4)  Protection of patient data.
• Close the timing gaps between information 
research studies and their application in 
healthcare operational settings.
Table	1.	Components	of	a	chronic	care	model	(Rachlis,	2006)	
Component Description
Organization of Health 
System
Leadership in chronic disease management (CDM) 
Goals for CDM 
Improvement strategy for CDM 
Incentives and regulations for CDM 
Benefits
Self-management support Assessment and documentation of needs and activities 
Addressing concerns of patients 
Effective behavior change interventions
Decision Support Evidence-based guidelines 
Involvement of specialists in improving primary care 
Providing education for CDM 
Informing patients about guidelines
Delivery System design Practice team functioning 
Practice team leadership 
Appointment system 
Follow-up 
Planned visits for CDM 
Continuity of Care
Clinical Information 
Systems
Registry 
Reminders to providers 
Feedback 
Information about relevant subgroups of patients needing services 
Patient treatment plans
Community Linkages for patients to resources 
Partnerships with community organizations 
Policy and plan development
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• Shorten the time cycle to fund an ICT 
project and receive an adequate return on 
the investment.
These 4 Ps were chosen after discussions 
with various healthcare professionals as to 
the areas they believed were critical inputs 
for any model. These categories are mutually 
exclusive and collectively exhaustive based on 
the views of experts consulted. In applying the 
INET-based solution to any particular context of 
diabetes sufferers it is necessary to consider the 
scope or extent of the diabetes problems in this 
context, the specific contextual features, such as 
demographics as well as current processes and 
legacy systems in place to treat patients so that 
the application will be tailored to this popula-
tion - hence “localize” it which constitutes an 
important aspect in the delivery framework. 
In addition, it is important to understand the 
make-up of the care team or field and finally 
the results that need to be evaluated. Thus, 
the delivery framework aids in making the 
solution applicable to any context of diabetic 
patients which is an essential consideration 
given that diabetes cuts across many areas of 
the community.
Together the components of the model will 
help in actualizing physician-led solution for the 
management of chronic diseases in general and 
of diabetes in particular. To successfully imple-
ment the INET web-based model described 
above, it was necessary to have an appropriate 
methodology. Based on this need, the adaptive 
mapping to realization methodology (AMR) 
was developed (Figure 2). The idea of the 
methodology was to apply a systematic rigorous 
set of predetermined protocols to each business 
case and then to map the post-prior results 
back to the model. In this way, it was possible 
to compare and contrast both a priori and post 
priori findings. From such a comparison, first 
a diagnosis of the current state was made then 
prescriptions were derived for the next business 
Figure	1.	INET	Web-based	model
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case. Hence, each pilot study incorporated the 
lessons learnt from the previous one and the 
model was adapted in real time.
By applying the tools and techniques of 
today’s knowledge economy as presented in an 
intelligence continuum (IC), it is possible to 
make the AMR methodology into a very pow-
erful knowledge-based systems development 
model. The IC was developed by Wickramas-
inghe and Schaffer (2006) to enable the ap-
plication of tools and technologies of the 
knowledge economy to be applied to healthcare 
processes in a systematic and rigorous fashion, 
thereby ensuring superior healthcare delivery. 
The collection of key tools, techniques and 
processes that make up the IC include, but are 
not limited to, data mining, business intelli-
gence/analytics and knowledge management 
(Wickramasinghe & Schaffer, 2006).
Taken together, the IC represents a very 
powerful system for refining the raw data stored 
in data marts and/or data warehouses, thereby 
maximizing the value and utility of these data 
assets for any organization. To maximize the 
value of the data generated through specific 
healthcare processes and then to use this to 
improve processes, IC techniques and tools 
must be applied in a systematic manner. Once 
applied, the results become part of the data 
set that are subsequently reintroduced into 
the system and combined with other inputs of 
people, processes, and technology to develop an 
improvement continuum. Thus, the IC includes 
the generation of data, the analysis of these data 
to provide a “diagnosis”, and their reintroduc-
tion into the cycle as a “prescriptive” solution. 
In this way, the IC is well suited to the dynamic 
and complex nature of healthcare environments 
and ensures that the future state is always built 
upon the extant knowledge-base of the preced-
ing state. Through the incorporation of the IC 
with the AMR methodology we then have a 
knowledge-based systems development model 
that can be applied to any setting, not necessarily 
to chronic disease management. The power of 
this model is that it iterates best practices and 
Figure	2.	AMR	methodology
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best available germane knowledge continually 
and is both flexible and robust.
Given the uniqueness of this approach it 
was necessary to develop this model separately 
rather than linking it to other existing models. 
This was done by first, trying to understand 
key criteria from various stakeholders such as 
patients, healthcare professionals and hospital 
personnel, and then, sorting the information 
into a coherent whole. This was an iterative 
process which involved multiple discussions 
with the various stakeholders until all parties 
achieve consensus that the model captured the 
essential elements as discussed in Goldberg 
(2002a, 2002b, 2002c, 2002d, 2002e).
To date directional data from Wickrama-
singhe and Goldberg (2007) have shown the 
potential benefits of this solution in various pilot 
studies in Canada. The research methodology 
adopted in these studies applied mixed method 
including standard qualitative and quantitative 
techniques such as survey, interview and eth-
nography focusing on a single exemplar case 
study. At all times a high level of research rigor 
was ensued by subscribing to recognized and 
standard practices as set out by Yin (1994), 
Boyatzis (1998), and Kavale (1996). We believe 
that DiaMonD is a beneficial solution given the 
huge and growing impact of diabetes generally 
and GDM in particular. In particular, it is very 
cost effective for both patients and healthcare 
providers. We believe that as more pilot studies 
are conducted in different settings this will add 
data that will show the full and far reaching 
benefits of the proposed solution. What is certain 
is that current methods for treating patients with 
diabetes are unwieldy, generating significant 
costs, not especially patient-centric and doing 
little to stem the development of secondary 
complications, suggesting that a better solution 
is needed. At this stage, the INET’s solution 
looks to be appropriate as it offers a real-time 
user-centric solution. It offers an innovative 
approach to transmit blood glucose readings 
for GDM patients while providing support and 
instant feedback to patients and clinicians on 
both mobile devices and web-browsers, signifi-
cantly enhancing accessibility and patient care. 
Additionally, the solution has the potential to 
establish critical self-management behaviors 
for GDM patients or, where they already exist, 
enhance them. It also addresses issues of exist-
ing solutions which either do not systematically 
capture glucose readings data or when they do, 
do not provide the data to clinicians in a timely 
manner (Farmer et al., 2005; Young et al., 2005).
Even so, DiaMonD represents a pervasive 
ICT enabled solution, which, while not exor-
bitantly expensive, can facilitate the superior 
monitoring of GDM (Figure 3). DiaMonD 
also enables patient empowerment by way of 
enhancing self-management. This is a desirable 
objective because it allows patients to become 
more like partners with their clinicians in the 
management of their own healthcare (Opie, 
1998; Radin, 2006) by enhancing the traditional 
clinical-patient interactions (Mirza, Norris, & 
Stockdale, 2008; Wickramasinghe, Troshani, 
& Goldberg, 2009, 2010).
A Preliminary Assessment of the 
Solution
Demand Uncertainty
Given the growing incidences of diabetes and 
GDM sufferers and the relative ineffectiveness 
of existing non-medical approaches (Reach 
et al., 2005), it is anticipated that upon being 
made available there will be demand for the 
proposed solution, i.e., DiaMonD. Additionally, 
costs incurred by diabetes patients to operate 
the solution, that is, to systematically send 
glucose readings to their diabetes healthcare 
professionals (Figure 3), are likely to be negli-
gible since data transfer charges have recently 
become inexpensive. It is, therefore, expected 
that uncertainty is not likely to adversely affect 
demand for a solution such as DiaMonD for 
self-management for diabetes patients generally, 
and GDM patients, in particular.
Task Complexity
We argue that the proposed solution is easy to 
use and useful for both diabetic patients and 
healthcare professionals. As shown in Figure 
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3, DiaMonD requires diabetes sufferers to in-
put their glucose readings systematically via a 
simple user interface before sending them for 
processing. In fact, the solution is very similar 
to Short Message Service (SMS) applications 
which are renowned for their popularity (Mack-
ay & Weidlich, 2007; O’Doherty et al., 2010; 
Oh et al., 2008). It is, therefore, anticipated that 
diabetes sufferers will find the solution easy to 
use and useful as also supported in preliminary 
studies and assessments in previous trials both in 
the US and Canada (Wickramasinghe & Gold-
berg, 2004, 2007; Wickramasinghe, Goldberg, 
& Bali, 2007, 2008). Additionally, healthcare 
professionals that have used the proposed 
solution have indicated that the functionality 
that concerns them (Figure 3) is also easy to 
use and useful (Wickramasinghe & Goldberg, 
2004, 2007; Wickramasinghe, Goldberg, & 
Bali, 2007, 2008). That is, the solution enables 
healthcare professionals to both monitor diabe-
tes trends and interact with patients relatively 
easily, inexpensively, and pervasively on both 
mobile device and browser interfaces. There-
fore, we speculate that DiaMonD complexity 
is not likely to present issues to users including 
diabetes sufferers and clinicians.
Asset Specificity
We anticipate that asset specificity will not 
constitute an obstacle for both diabetic pa-
tients and healthcare professionals. From the 
patients’ viewpoint, operating the proposed 
solution entails a mobile handset and a data 
plan. Current evidence shows that in many 
countries worldwide, including Australia, mo-
bile penetration rates exceed 100% (Netsize, 
2009; Rao & Troshani, 2006). Evidence also 
shows increasing trends of usage of mobile data 
services suggesting that there is growing num-
bers of mobile phone users that are subscribing 
to mobile data plans (Informa, 2005a, 2005b, 
2006; Netsize, 2009; Rao & Troshani, 2006). 
Therefore, DiaMonD in its capacity as a mobile 
diabetes self-management solution can be run 
on assets, i.e., mobile handset, which diabetic 
Figure	3.	ICT	Support	for	diabetes
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patients are likely to possess. Similar arguments 
can be made for healthcare professionals and 
their organizations. Additionally, healthcare 
professionals may also access DiaMonD sum-
maries (Figure 3) using web browser interfaces 
which only require computers connected to the 
Internet and are not expected to require specific 
expensive assets. Thus, it is anticipated that aside 
from software upgrades in existing servers and 
corresponding license fees, upgrades to new 
assets including computer hardware, are most 
likely unnecessary.
Frequency
We anticipate that interaction frequency be-
tween diabetic patients and healthcare providers 
using the proposed mobile solution will be high, 
though dictated by particular treatment regimen 
that healthcare professionals assigned to their 
patients. For example, some patients may be 
required to send their glucose readings to their 
healthcare professional six times daily, i.e., three 
times daily before and after each meal, while 
other patients may be required to fulfill differ-
ent patterns. We infer that interaction frequency 
is only a means of maximizing cost efficien-
cies, but also as a way of strengthening and 
complementing long term patient-healthcare 
professional relationships thereby improving 
the overall quality of healthcare services offered.
DISCUSSION
Based on our initial exploratory evaluation, 
the DiaMonD solution does appear to provide 
key benefits to GDM patients. Specifically, it 
would appear that the solution facilitates self-
management and cost effective, convenient 
care. Naturally, specific costs depend largely on 
the particular phone provider and phone plan. 
However, evidence shows that most individu-
als today who have mobile phones also have 
mobile phone plans. Given the small size of the 
data that is transferred in the solution strategy 
outlined above, in most cases this is well within 
the allowable amount of most phone plans, and 
hence, it is logical to assume that for most indi-
viduals they would in fact pay little to no extra 
charges for their glucose data transfer. Further, 
costs to healthcare providers would depend on 
various specific and respective arrangements 
these providers have with their existing ICT 
infrastructure but in general the DiaMonD 
solution provides them with an opportunity 
for significant cost savings and streamlining 
of patient data and workflow. This, in turn, is 
likely to provide them with better processes and 
subsequent savings with regard to non-billable 
hours. Finally, for insurers better management 
of GDM patients translates into potentially 
fewer healthcare problems, and hence, also 
fewer claims, thereby adding to cost savings.
Limitations
This paper serves to provide an exploratory 
investigation using an exemplar case study to 
identify the potential benefits of a pervasive 
technology solution for gestational diabetic 
patients. To the best of our knowledge no other 
software solution currently exists that spe-
cifically focuses on the management of GDM 
patients. As noted by Yin (1994), exploratory 
exemplar case studies are essential when there 
is a paucity of studies in a particular area so 
that it is possible to begin to build theory and 
awareness. We have attempted to accomplish 
this and reported the proposed model and the 
manner in which DiaMonD works in the pre-
ceding section. However, like all exploratory 
research, it has certain limitations including the 
fact that the major focus and assessment was 
based on the DiaMonD solution. We wish to 
point out that presenting an objective assess-
ment of this solution should not be seen as either 
endorsing or not endorsing a specific solution; 
rather, we present the case in order to provide 
a preliminary transactional cost perspective. 
Costs in healthcare are a very critical issue and 
without careful assessment of actual data it is 
not possible to understand, let alone address or 
provide recommendations regarding these sig-
nificant costs issues and implications. Moreover, 
the findings pertaining to better management 
of GDM patients cannot just be translated to 
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all patients suffering with diabetes without 
further research. This is a relatively common 
limitation when using an exemplar case study 
approach, but as noted by Yin (1994), the 
benefits of the use of an exemplar case study 
approach; most notably, being able to examine 
a relatively unique context and thereby develop 
awareness and theory to then perform follow 
up confirmatory analysis, which should not be 
neglected or sacrificed due to a lack of finding 
other comparative cases. Clearly then, future 
research must involve expanding this view and 
duplicating our initial findings and directional 
data to provide a more substantive comparison 
with other potential technology solutions that 
purport to facilitate self-management for dia-
betes sufferers.
Another area that will form the focus of 
future research is to investigate important is-
sues such as the transferability of this solution 
between different healthcare systems e.g., in 
USA versus Canada versus Australia. In this 
way, it will be possible to specifically identify 
local and global benefits that pervasive tech-
nology solutions can bring to chronic disease 
management. This paper has provided us with 
many areas for future work. In addition to 
those areas already mentioned, future work 
will also be needed to focus on moving forward 
on designing and developing the necessary 
strategies for general and widespread adoption 
of pervasive technologies to support superior 
self-management as we are convinced this is 
of critical importance to healthcare delivery.
CONCLUSION
Given the general global consensus that effec-
tive and efficient healthcare delivery will only 
occur through the judicious application of ICTs 
(News-Medical, 2004; Kulkarni & Nathanson, 
2005; Lacroix, 1999; Porter & Tiesberg, 2006; 
Wickramasinghe, 2007), it is inevitable that, 
as we move into the second decade of the 21st 
century, the prevalence of ICTs to facilitate 
the delivery of value-driven healthcare will 
increase. In such a climate, pervasive technology 
solutions like DiaMonD will be even more ap-
propriate, not only because such solutions utilize 
ICTs to provide superior healthcare delivery in 
the case of GDM patients, but also because such 
solutions are both simple to implement and use, 
and also cost effective both at the micro and 
macro levels. These levels include individual 
patients, clinicians and organizations, including 
public and private healthcare providers.
We set out here to present a case for the need 
to embrace a pervasive technology solution for 
the superior monitoring of self-management for 
women suffering from gestational diabetes in 
Australia. In so doing, we have also provided a 
preliminary transaction cost assessment, which 
highlights the benefits of such a solution. We 
contend that there is a major role for pervasive 
technology solutions such as INET’s DiaMonD 
in the context of gestational diabetes and infer 
that similar benefits should also be realized 
in the context of controlling both type I and 
type II diabetes. Further, we hypothesize that 
pervasive technology solutions are likely to be 
as effective irrespective of patient’s age, socio-
economic standing or location, have minimal 
risks and a very slight learning curve (if at 
all). Moreover, we speculate that, if pervasive 
technology solutions such as DiaMonD and its 
underlying model were to be incorporated into 
the Australian context, the growing segment of 
the population suffering from diabetes would 
have a convenient, cost effective and superior 
means of monitoring, and thereby controlling, 
their diabetes while, in turn, enjoying a better 
quality of life. In addition, it is equally important 
to note that such pervasive technology solutions 
can also facilitate the work of governments, 
healthcare associations, pharmaceutical firms, 
researchers, healthcare professionals and other 
key healthcare stakeholders that are looking 
for improved means and better measurable 
outcomes among patients suffering from dia-
betes. Specific benefits range from decreasing 
diabetes-related complications to reducing the 
economic burden on the health system.
This paper, then, serves to provide a sys-
tematic evaluation of an exemplar case study of 
the benefits of a pervasive technology solution 
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to facilitate superior self-management. In so 
doing, it provides an important contribution to 
the extant literature in trying to move medical 
practice and healthcare delivery forward in a 
number of very vital areas, including diabetes 
self-management, best practices and pervasive 
technology solution. In closing, we realize that 
further research is required to test DiaMonD 
and other similar software in the Australian 
healthcare setting as well as the generalizability 
of such solutions in other context of diabetes 
both within Australia and throughout the world. 
However, our directional data to date provides 
a compelling case for the role of pervasive 
technology solutions to be incorporated into 
the treatment of patients suffering from dia-
betes and we conclude by suggesting that, if 
pervasive technology solutions are not sought 
for the monitoring and support of diabetes 
self-management for both GDM sufferers as 
well as all diabetes sufferers, then this chronic 
disease, which is already at pandemic levels, will 
continue to be a very costly burden for both the 
healthcare sector and the community at large.
REFERENCES
AIHW. (2007). National	indicators	for	monitoring	
diabetes:	Report	of	the	diabetes	indicators	review	
subcommittee	of	the	National	Diabetes	Data	Working	
Group. Canberra, Australia: Australian Institute of 
Health and Welfare (AIHW).
AIHW. (2008). Diabetes:	 Australian	 facts	 2008. 
Canberra, Australia: Australian Institute of Health 
and Welfare (AIHW).
Balas, E. A., Krishna, S., Kretschmer, R. A., Cheek, 
T. R., Lobach, D. F., & Boren, S. A. (2004). Com-
puterized knowledge management in diabetes care. 
Medical	 Care, 42(6), 610–621. doi:10.1097/01.
mlr.0000128008.12117.f8
Bodenheimer, T., Lorig, K., Holman, H., & 
Grumbach, K. (2002). Patient self-management 
of chronic disease in primary care. Journal	of	the	
American	Medical	Association, 288(19), 2469–2475. 
doi:10.1001/jama.288.19.2469
Boyatzis, R. (1998). Transforming	 qualitative	 in-
formation	thematic	analysis	and	code	development. 
Thousand Oaks, CA: Sage.
Britt, H., Miller, G. C., Charles, J., Pan, Y., Valenti, 
L., Henderson, J., et al. (2007). General	practice	
activity	 in	Australia	 2005-06 (Cat. No. GEP 16). 
Canberra, Australia: Australian Institute of Health 
and Welfare (AIHW).
Carolan, M. C., Steele, C., & Margetts, H. (2010). 
Attitudes towards gestational diabetes among a 
multi-ethnic cohort in Australia. Journal	of	Clinical	
Nursing, 19(17-18), 2446–2453. doi:10.1111/j.1365-
2702.2010.03305.x
Catanzariti, L., Faulks, K., & Waters, A.-M. (2007). 
National	diabetes	register:	Statistical	profile	1999-
2005 (AIHW Cat. No. CVD 39). Canberra, Australia: 
Australian Institute of Health and Welfare (AIHW).
Chau, S., & Turner, P. (2006). Utilisation of mobile 
handheld devices for care management at an Aus-
tralian aged care facility. Electronic	Commerce	Re-
search	and	Applications, 5, 305–312. doi:10.1016/j.
elerap.2006.04.005
Chittleborough, C. R., Grant, J. F., Phillips, P. J., & 
Taylor, A. W. (2007). The increasing prevalence of 
diabetes in South Australia: the relationship with 
population ageing and obesity. Public	Health, 121, 
92–99. doi:10.1016/j.puhe.2006.09.017
Colagiuri, S., Colagiuri, R., & Ward, J. (1998). Na-
tional	diabetes	strategy	and	implementation	plan. 
Canberra, Australia: Diabetes Australia.
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, 
A. J., Jeffries, W. S., & Robinson, J. S. (2005). The 
effect of treatment of gestational diabetes mellitus 
on pregnancy outcomes. The	New	England	Journal	
of	 Medicine, 352, 2477–2486. doi:10.1056/NEJ-
Moa042973
DiabCostAustralia. (2002). Assessing	 the	 burden	
of	type	2	diabetes	in	Australia. Adelaide, Australia: 
DiabCost Australia.
DiabetesAustralia. (2008). Diabetes	 in	 Australia. 
Retrieved from http://www.diabetesaustralia.com.
au/Understanding-Diabetes/Diabetes-in-Australia/
Dixon, T., & Webbie, K. (2006). The	national	system	
for	monitoring	diabetes	in	Australia	(AIHW	Cat.	No.	
CVD	32). Canberra, Australia: Australian Institute 
of Health and Welfare.
Downer, S. R., Meara, J. G., Da Costa, A. C., & 
Sethuraman, K. (2006). SMS text messaging im-
proves outpatient attendance. Australian	 Health	
Review, 30(3), 389–396. doi:10.1071/AH060389
International Journal of Healthcare Information Systems and Informatics, 6(4), 60-76, October-December 2011   73
Copyright © 2011, IGI Global. Copying or distributing in print or electronic forms without written permission of IGI Global is prohibited.
Fan, Z., Yang, H., Gao, H., Lintu, H., & Sun, W. 
(2006). Pregnancy outcome in gestational diabetes. 
International	Journal	of	Gynaecology	and	Obstet-
rics:	the	Official	Organ	of	the	International	Federa-
tion	of	Gynaecology	and	Obstetrics, 94(1), 12–16. 
doi:10.1016/j.ijgo.2006.03.021
Farmer, A., Gibson, O., Hayton, P., Bryden, K., 
Dudley, C., & Neil, C. (2005). A real-time, mobile 
phone-based telemedicine system to support young 
adults with type 1 diabetes. Informatics	in	Primary	
Care, 13(3), 171–177.
Goldberg, S. (2009). An	evolution	of	using	social	
networks	 in	 chronic	 disease	 management. Paper 
presented at the 22nd Bled eConference: Facilitat-
ing an Open, Effective and Representative Society, 
Bled, Slovenia.
Goldberg, S. (2002a). Building	the	evidence	for	a	
standardized	mobile	Internet	(wireless)	environment	
in	Ontario,	Canada,	January	update	(Internal	INET	
documentation). Toronto, ON, Canada: INET.
Goldberg, S. (2002b). HTA	presentational	selection	
and	aggregation	component	summary	(Internal	INET	
documentation). Toronto, ON, Canada: INET.
Goldberg, S. (2002c). Wireless	POC	device	 com-
ponent	 summary	 (Internal	 INET	 documentation). 
Toronto, ON, Canada: INET.
Goldberg, S. (2002d). HTA	presentation	rendering	
component	summary	(Internal	INET	documentation). 
Toronto, ON, Canada: INET.
Goldberg, S. (2002e). HTA	quality	assurance	com-
ponent	 summary	 (Internal	 INET	 documentation). 
Toronto, ON, Canada: INET.
Hesterly, W. S., Liebeskind, J., & Zenger, T. R. (1990). 
Organizational economics: an impeding revolution 
in organizational theory. Academy	of	Management	
Review, 15(3), 402–420.
Hesterly, W. S., & Zenger, T. R. (1993). The myth 
of a monolithic economics: Fundamental assump-
tions and the use of economic models in policy and 
strategy research. Organization	Science, 4, 496–510. 
doi:10.1287/orsc.4.3.496
Hoffman, L., Nola, C., Wilson, J. D., & Oats, J., 
J. N., & Simmons, D. (1998). Gestational diabetes 
mellitus – management guidelines. The	 Medical	
Journal	of	Australia, 169, 93–97.
Hunt, D. (2007). Urgent	health	system	reform	needed	
to	tackle	disease	epidemic,	says	head	of	new	Uni-
versity	of	Melbourne	centre. Retrieved November, 
25, 2008, from http://uninews.unimelb.edu.au/view.
php?articleID=4615
ICIC. (2008). Improving	chronic	illness	care:	The	
chronic	 care	 model. Retrieved from http://www.
improvingchroniccare.org/indix.php?p=The_Chron-
ic_Care_Model&s=2
Informa. (2005a). Mobile	 content	 and	 services:	
Worldwide	 market	 analysis	 &	 strategic	 outlook. 
London, UK: Informa Telecoms & Media.
Informa. (2005b). Global	mobile	forecasts	to	2010:	
Worldwide	 market	 analysis	 &	 strategic	 outlook	
2005-2010 (5th ed.). London, UK: Informa Tele-
coms & Media.
Informa. (2006). Global	Mobile:	The	International	
Business	 Newsletter	 of	 Mobile	 Communications	
Markets,	13(6). London, UK: Informa.
Jones, C., Hesterly, W. S., & Borgatti, S. P. (1997). 
A general theory of network governance: exchange 
conditions and social mechanisms. Academy	 of	
Management	Review, 22(4), 911–945.
Kavale, S. (1996). Interviews,	 an	 introduction	 to	
qualitative	research. London, UK: Sage.
Kim, C., Berger, D. K., & Chamany, S. (2007). Recur-
rence of gestational diabetes mellitus: a systematic 
review. Diabetes	Care, 30, 1314–1319. doi:10.2337/
dc06-2517
Knuiman, M. W., Welborn, T. A., & Bartholomew, 
H. C. (1996). Self-reported health and use of health 
services: a comparison of diabetic and nondiabetic 
persons from a national sample. Australian	and	New	
Zealand	Journal	of	Public	Health, 20(3), 241–247. 
doi:10.1111/j.1467-842X.1996.tb01023.x
Kulkarni, R., & Nathanson, L. A. (2005). Medicine	
informatics	in	medicine. Retrieved from http://www.
emedicine.com/emerg/topic879.htm
Lacroix, A. (1999). International concerted action on 
collaboration in telemedicine: G8sub-project 4. Stud-
ies	in	Health	Technology	and	Informatics, 64, 12–19.
Landon, M. B., Spong, C. Y., Thom, E., Carpenter, M. 
W., Ramin, S. M., & Casey, B. (2009). A multicenter, 
randomized trial of treatment for mild gestational 
diabetes. The	New	England	 Journal	 of	Medicine, 
361, 1339–1348. doi:10.1056/NEJMoa0902430
Mackay, M. M., & Weidlich, O. (2007, March 
2007). Australian	mobile	phone	lifestyle	index (3rd 
ed.). Perth, Australia: Australian Interactive Media 
Industry Association (AIMIA), Mobile Content 
Industry Development Group (MCIDG). Retrieved 
8 April, 2007, from http://www.aimia.com.au/mobile
74   International Journal of Healthcare Information Systems and Informatics, 6(4), 60-76, October-December 2011
Copyright © 2011, IGI Global. Copying or distributing in print or electronic forms without written permission of IGI Global is prohibited.
Metzger, B. E., Lowe, L. P., Dyer, A. R., Trimble, 
E. R., Chaovarindr, U., & Coustan, D. R. (2008). 
Hyperglycemia and adverse pregnancy outcomes. 
The	New	England	 Journal	 of	Medicine, 358(19), 
1191–2002.
Milliken, F. J. (1987). Three types of perceived 
uncertainty about the environment: state, effect, 
and response uncertainty. Academy	of	Management	
Review, 12(1), 133–143.
Mirza, F., Norris, T., & Stockdale, R. (2008). Mo-
bile technologies and the holistic management of 
chronic diseases. Health	Informatics	Journal, 14(4), 
309–321. doi:10.1177/1460458208096559
Netsize. (2009). Netsize	guide	2009	edition:	Mobile	
society	and	me:	When	worlds	combine. Levallois-
Perret, France: Netsize.
News-Medical. (2004, May 11). Frost	and	Sullivan	
country	 industry	 forecast. Retrieved from http://
www.news-medical.net/print_article.asp?id=1405
O’Doherty, K., Rao Hill, S., Mackay, M. M., & 
McPherson, J. (2010). Mobile data service usage and 
preference: an investigation of Australian consumers. 
International	Journal	of	Mobile	Communications, 
8(1), 106–127. doi:10.1504/IJMC.2010.030523
Oh, S., Yang, S., Kurnia, S., Lee, H., Mackay, M. 
M., & O’Doherty, K. (2008). The characteristics 
of mobile data users in Australia. International	
Journal	of	Mobile	Communications, 8(2), 217–230. 
doi:10.1504/IJMC.2008.016578
Opie, A. (1998). Nobody’s asked me for my view: 
users’ empowerment by multidisciplinary health 
teams. Qualitative	Health	Research, 18, 188–206. 
doi:10.1177/104973239800800204
Pfeffer, J., & Salancik, G. R. (1978). The	external	
control	 of	 organizations:	 a	 resource	 dependence	
perspective. New York, NY: Harper & Row.
Porter, M., & Tiesberg, E. (2006). Re-defining	health	
care	delivery. Boston, MA: Harvard Business Press.
Poulton, B. C. (1999). User involvement in iden-
tifying health needs and shaping and evaluating 
services: is it being raised? Journal	 of	Advanced	
Nursing, 30(6), 1289–1296. doi:10.1046/j.1365-
2648.1999.01224.x
Rachlis, M. (2006). Key	to	sustainable	healthcare	
system. Retrieved 21 June, 2008, from http://www.
improveinchroniccare.org
Radin, P. (2006). To me, it’s my life: medical com-
munication, trust, and activism in cyberspace. Social	
Science	 &	 Medicine, 6, 591–601. doi:10.1016/j.
socscimed.2005.06.022
Rao, S., & Troshani, I. (2006). AMC-ER	preliminary	
research	report:	Understanding	market	and	mobile	
content	selection	for	distribution. Adelaide, South 
Australia: Australian Mobile Content – Export Re-
search Initiative, m.Net.
Rasmussen, B., Wellard, S., & Nankervis, A. (2001). 
Consumer issues in navigating health care services 
for type I diabetes. Journal	of	Clinical	Nursing, 10, 
628–634. doi:10.1046/j.1365-2702.2001.00550.x
Reach, G., Zerrouki, D., Leclercq, D., & d’Ivernois, 
J. F. (2005). Adjusting insulin doses: from knowledge 
to decision. Patient	Education	and	Counseling, 56(1), 
98–103. doi:10.1016/j.pec.2004.01.001
Rudi, R., & Celler, B. G. (2006, December 11-14). 
Design and implementation of expert-telemedicine 
system for diabetes management at home. In Pro-
ceedings	 of	 the	 IEEE	 International	 Conference	
on	 Biomedical	 and	 Pharmaceutical	 Engineering, 
Singapore.
Rumbold, A. R., & Crowther, C. A. (2001). Guide-
line use for gestational diabetes mellitus and current 
screening, diagnostic and management practices in 
Australian hospitals. Australian	and	New	Zealand	
Journal	of	Obstetrics	and	Gynaecology, 41, 86–90. 
doi:10.1111/j.1479-828X.2001.tb01301.x
Rumbold, A. R., & Crowther, C. A. (2002). Women’s 
experiences of being screened for gestational diabe-
tes mellitus. Australian	and	New	Zealand	Journal	
of	 Obstetrics	 and	 Gynaecology, 42, 131–137. 
doi:10.1111/j.0004-8666.2002.00131.x
Russell, L. B., Churl Suh, D., & Safford, M. M. 
(2005). Time requirements for diabetes manage-
ment: too much for many? The	Journal	of	Family	
Practice, 54(1), 52–56.
Sprivulis, P., Walker, J., Johnston, D., Pan, E., Adler-
Milstein, J., & Middleton, B. (2007). The economic 
benefits of health information exchange interoper-
ability. Australian	Health	Review, 31(4), 531–539. 
doi:10.1071/AH070531
Swerissen, H., & Taylor, M. J. (2008). Reforming 
funding for chronic illness: Medicare-CDM. Aus-
tralian	Health	Review, 32(1), 76–84. doi:10.1071/
AH080076
International Journal of Healthcare Information Systems and Informatics, 6(4), 60-76, October-December 2011   75
Copyright © 2011, IGI Global. Copying or distributing in print or electronic forms without written permission of IGI Global is prohibited.
Troshani, I., & Rao, S. (2007a). The diffusion of 
mobile services in Australia: an evaluation using 
stakeholder and transaction cost economics theories. 
IADIS	 International	 Journal	 of	 WWW/Internet,	
5(2), 40-57.
Van Eyk, H., & Baum, F. (2002). Learning about 
interagency collaboration: Trialling collaborative 
projects between hospitals and community health ser-
vices. Health	&	Social	Care	in	the	Community, 10(4), 
262–269. doi:10.1046/j.1365-2524.2002.00369.x
Wellard, S. J., Rennie, S., & King, R. (2008). Per-
ceptions of people with type 2 diabetes about self-
management and the efficiency of community based 
services. Contemporary	 Nurse, 29(2), 218–226. 
doi:10.5172/conu.673.29.2.218
Wickramasinghe, N. (2007). Fostering knowledge as-
sets in healthcare with the KMI model. International	
Journal	of	Management	and	Enterprise	Develop-
ment, 4(1), 52–65. doi:10.1504/IJMED.2007.011455
Wickramasinghe, N., & Goldberg, S. (2003, Janu-
ary 6-10). The wireless panacea for healthcare. In 
Proceedings	of	the	36th	IEEE	Hawaii	International	
Conference	on	System	Sciences.
Wickramasinghe, N., & Goldberg, S. (2004). How 
M=EC2 in healthcare. International	Journal	of	Mo-
bile	Communications, 2(2), 140–156. doi:10.1504/
IJMC.2004.004664
Wickramasinghe, N., & Goldberg, S. (2007). Adap-
tive mapping to realisation methodology (AMR) to 
facilitate mobile initiatives in healthcare. Interna-
tional	 Journal	 of	 Mobile	 Communications, 5(3), 
300–318. doi:10.1504/IJMC.2007.012396
Wickramasinghe, N., Goldberg, S., & Bali, R. 
(2007). Enabling superior m-health project success: 
a tri-country validation. International	 Journal	 of	
Services	and	Standards, 4(1), 97–117. doi:10.1504/
IJSS.2008.016087
Wickramasinghe, N., Goldberg, S., & Bali, S. 
(2008). Enabling superior m-health project success: 
a tri-country validation. International	 Journal	 of	
Services	and	Standards, 4(1), 97–117. doi:10.1504/
IJSS.2008.016087
Wickramasinghe, N., & Schaffer, J. (2006). Creat-
ing knowledge driven healthcare processes with the 
intelligence continuum. International	 Journal	 of	
Electronic	Healthcare, 2(2), 164–174.
Wickramasinghe, N., Troshani, I., & Goldberg, S. 
(2009). Supporting diabetes self-management with 
pervasive wireless technology solutions. Interna-
tional	Journal	of	Healthcare	Delivery	Reform	Initia-
tives, 1(4), 17–31. doi:10.4018/jhdri.2009100102
Wickramasinghe, N., Troshani, I., & Goldberg, S. 
(2010). An investigation into the use of pervasive 
wireless technologies to support diabetes healthcare. 
In Coronato, A., & De Pietro, G. (Eds.), Pervasive	
and	smart	technologies	for	healthcare:	Ubiquitous	
methodologies	and	tools (Vol.	114-129). New York, 
NY: IGI Global. doi:10.4018/978-1-61520-765-7.
ch006
Wild, S., Roglic, G., Green, A., Sicree, R., & King, 
H. (2004). Global prevalence of diabetes: estimates 
for the year 2000 and projections for 2030. Diabetes	
Care, 27, 1047–1053. doi:10.2337/diacare.27.5.1047
Williamson, O. E. (1985). The	 economic	 institu-
tions	of	capitalism:	Firms,	markets,	and	relational	
contracting. New York, NY: Free Press.
Williamson, O. E. (1991). Comparative economic 
organization: The analysis of discrete structural 
alternatives. Administrative	Science	Quarterly, 36, 
269–296. doi:10.2307/2393356
Yin, R. (1994). Case	 study	 research:	Design	and	
methods. Newbury Park, CA: Sage.
Young, R. J., Taylor, J., Friede, T., Hollis, S., Ma-
son, J. M., & Lee, P. (2005). Pro-active call centre 
treatment support (PACCTS) to improve glucose 
control in type 2 diabetes: a randomized controlled 
trial. Diabetes	Care, 28(2), 278–282. doi:10.2337/
diacare.28.2.278
Zigbor, J. C., & Songer, T. J. (2001). External barri-
ers to diabetes care: addressing personal and health 
systems issues. Diabetes	 Spectrum, 14, 23–28. 
doi:10.2337/diaspect.14.1.23
76   International Journal of Healthcare Information Systems and Informatics, 6(4), 60-76, October-December 2011
Copyright © 2011, IGI Global. Copying or distributing in print or electronic forms without written permission of IGI Global is prohibited.
Nilmini	Wickramasinghe	received	her	PhD	from	Case	Western	Reserve	University,	USA	and	
currently	is	the	Epworth	Chair	in	Health	Information	Management	and	a	professor	at	RMIT	
University,	Australia.	She	researches	and	teaches	within	the	information	systems	domain	with	
a	special	focus	on	IS/IT	solutions	to	effect	superior,	patient	centric	healthcare	delivery.	She	has	
collaborated	with	leading	scholars	at	various	premier	healthcare	organizations	throughout	US	
and	Europe.	She	is	well	published	with	more	than	200	referred	scholarly	articles,	10	books,	
numerous	book	chapters,	an	encyclopedia	and	a	well	established	funded	research	track	record.
Indrit	Troshani	is	a	senior	lecturer	at	the	University	of	Adelaide	Business	School.	He	holds	a	
PhD	in	computer	science	from	Edith	Cowan	University	(Western	Australia),	an	MSc	in	computer-
based	information	systems	(Sunderland,	UK),	and	a	BBA	(Hons)	from	Malaysia.	His	research	
interests	and	contributions	include	adoption	and	diffusion	of	mobile	services	and	applications	in	
healthcare	and	network	innovations	in	Business-to-Business	(B2B)	settings.	Dr	Indrit	Troshani	
has	been	doing	research	in	the	area	of	m-commerce	and	e-business	since	he	joined	the	University	
of	Adelaide	Business	School	in	July	2003.
Sally	Rao	Hill	is	a	senior	lecturer	at	the	business	school	of	the	University	of	Adelaide.	She	
is	an	active	researcher	in	the	area	of	marketing	and	information	systems.	She	has	published	
in	leading	academic	journals,	presented	papers	at	leading	academic	conferences	and	is	an	
ad	hoc	reviewer	of	several	academic	journals.	One	of	her	papers	has	won	the	“Best	Paper”	
in	an	international	conference.	She	has	written	8	book	chapters	and	several	case	studies	for	
marketing	textbooks.	Her	research	has	been	published	in	the	European Journal of Marketing,	
Australasian Marketing Journal,	Industrial and Business Marketing,	Young Consumers,	Journal 
of Mobile Communications.
William	Hague,	 for	 the	 last	 21	 years,	 has	been	 living	and	working	 in	Adelaide,	 both	as	an	
academic	within	what	is	now	the	Discipline	of	Obstetrics	and	Gynaecology	in	the	School	of	
Paediatrics	and	Reproductive	Health	at	The	University	of	Adelaide,	and	clinically,	in	Obstetric	
Medicine	at	the	Women’s	and	Children’s	Hospital	(W&CH)	in	Adelaide,	first	as	a	senior	visiting	
medical	specialist	and	subsequently	as	a	senior	consultant.	He	has	contributed	to	the	research	
output	of	the	University	department,	with	three	NHMRC	project	grants	as	well	as	other	major	
international	and	local	funding,	with	over	80	contributions	to	the	literature	in	refereed	journals	
and	books,	focussing	on	medical	problems	in	pregnancy,	particularly	in	the	areas	of	diabetes,	
pre-eclampsia,	clotting	disorders	and	liver	disease,	with	both	clinical	and	laboratory	projects.
Steve	Goldberg	founded	INET	International	Inc.	in	1998.	As	INET’s	president	he	leads	the	firm	in	
data	collection	for	international	research	studies,	wireless	healthcare	programs	and	INET	Mini-
conferences.	Mr.	Goldberg	started	his	21-year	information	technology	career	at	Systemhouse	Ltd.	
At	Crowntek,	he	formed	an	executive	collaboration	to	develop	a	$30	million	IT	services	business.	
During	his	tenure	at	Cybermation,	he	transformed	the	organization	from	supporting	mainframe	
applications	to	client/server	applications.	Prior	to	INET,	at	Compugen	he	successfully	built	a	
high-performance	team	to	meet	government	and	corporate	e-business	needs.
